Crinetics Pharmaceuticals Inc (CRNX)
Stock-Based Compensation
$24.88M
Quarterly · Period ending: · USD
CRNX Stock-Based Compensation
Latest reported$24.88Mperiod ending
Latest reported$24.88Mperiod ending
CRNX Quarterly Stock-Based Comp ($56.00K → $24.88M)
Quarterly stock-based compensation
High-resolution chart · PNG
CRNX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 24,881,000 | |
| 29,680,000 | |
| 21,720,000 | |
| 22,702,000 | |
| 26,124,000 | |
| 20,478,000 | |
| 18,845,000 | |
| 18,147,000 | |
| 18,940,000 | |
| 13,454,000 | |
| 11,617,000 | |
| 11,049,000 | |
| 10,175,000 | |
| 0 | |
| 0 | |
| 7,434,000 | |
| 0 | |
| 0 | |
| 5,158,000 | |
| 4,555,000 | |
| 4,233,000 | |
| 3,406,000 | |
| 0 | |
| 2,781,000 | |
| 2,528,000 | |
| 2,147,000 | |
| 0 | |
| 1,854,000 | |
| 1,581,000 | |
| 1,028,000 | |
| 847,000 | |
| 775,000 | |
| 272,000 | |
| 426,000 | |
| 72,000 | |
| 71,000 | |
| 72,000 | |
| 56,000 |